Is Health In Tech, Inc. (HIT) a Buy, Sell, or Hold?
NASDAQ : HIT
Health In Tech, Inc.
$1.13 USD
$0.06 (5.61%)
- Volume
- 137.96K
- Average Volume
- 188.99K
- Market Capitalization
- $60.86M
- P/E Ratio
- -59.16
- Dividend Yield
- 0.00%
- Price Target
- $4.00
- Year High
- $4.02
- Year Low
- $0.85
- Day High
- —
- Day Low
- —
- Payout Ratio
- $0.00
- Current Ratio
- $3.13
Company Overview
NASDAQ
Tim Johnson
Software - Application
Technology
HIT
91
US
USD
Liquidity Metrics
0.01
3.13
3.13
1.47
0.00
Sales & Valuation
$33.33M
1.79
3.00
-50.58
-0.02
Profitability
$0.02
$1.28M
-2.37%
-3.16%
-4.47%
-2.79%
P/E Metrics
-59.16
0.30
0.30
Analyst Price Target & Rating
$4.00
$4.00
$4.00
2/5
0 Analysts
-71.75%
Poll Results
About Health In Tech, Inc. (NASDAQ:HIT) Stock
Health In Tech, Inc. operates as a cutting-edge insurance technology provider. The company delivers a range of specialized insurance solutions for smaller enterprises, such as value-based pricing strategies, group insurance captives, localized community health plans, and collective association health programs. Additionally, it offers the enhanced "do it yourself" benefit system (eDIYBS), a cloud-based SaaS platform engineered to efficiently generate health insurance quotes for small to medium-sized businesses. Health In Tech further supports healthcare administration with its "health intelligence" (HI) card, which streamlines the management of medical records and claims. Complementing this is the HI performance network, an extensive series of medical facilities that utilize Medicare-based ... reimbursement pricing. This organization was established in 2014 and its principal offices are located in Stuart, Florida.
Health In Tech Added to Membership of Russell Microcap® Index
2026-06-29 06:00:00
STUART, Fla., June 29, 2026 /PRNewswire/ -- Health In Tech, Inc. (Nasdaq: HIT) ("Health In Tech" or the "Company") was added as a member of the Russell Microcap® Index, effective when the U.S. market opens on June 29, 2026, as part of the 2026 Russell U.S. indexes reconstitution.
Health In Tech, Inc. (HIT) Q1 2026 Earnings Call Transcript
2026-05-14 09:31:13
Health In Tech, Inc. (HIT) Q1 2026 Earnings Call Transcript
Health In Tech Q1 Earnings Call Highlights
2026-05-13 20:14:29
Health In Tech NASDAQ: HIT reported first-quarter 2026 revenue growth and a wider loss as management said the company is intentionally increasing investment in sales distribution, carrier relationships and technology development to pursue a larger share of the self-funded health insurance market.
Health In Tech Reports First Quarter 2026 Financial Results
2026-05-13 16:00:00
Reiterates Guidance for 2026 Annual Revenue Ranging between $45 Million and $50 Million STUART, Fla., May 13, 2026 /PRNewswire/ -- Health In Tech, Inc. (Nasdaq: HIT) ("Health In Tech" or "Company"), an AI-enabled InsurTech platform company, today announced its unaudited financial results for the three months ended March 31, 2026.
Health In Tech to Announce First Quarter 2026 Financial Results on May 13, 2026
2026-04-30 16:01:00
STUART, Fla., April 30, 2026 /PRNewswire/ -- Health In Tech, Inc. (Nasdaq: HIT), an AI-enabled InsurTech platform company, today announced that it will release financial results for the first quarter ended March 31, 2026, following the close of market on Wednesday, May 13, 2026.
2026-04-30 08:30:00
FDA provided critical guidance for the advancement of CAD-1005 to pivotal Phase 3 in HIT Phase 2 data showed a greater than 25% absolute reduction in thrombotic events when CAD-1005 was added to standard anticoagulant therapy PONTE VEDRA, Fla., April 30, 2026 (GLOBE NEWSWIRE) -- Cadrenal Therapeutics, Inc. (Nasdaq: CVKD), a biopharmaceutical company developing innovative treatments for life-threatening immune and thrombotic conditions, today announced a major regulatory milestone after successfully completing its End-of-Phase 2 (EOP2) meeting with the U.S. Food and Drug Administration (FDA) and receiving guidance on key elements of the Phase 3 pivotal trial for CAD-1005, the Company's investigational first-in-class 12-lipoxygenase (12-LOX) inhibitor for heparin-induced thrombocytopenia (HIT).
Health In Tech to Present at the Market Movers Investor Summit
2026-04-21 16:00:00
STUART, Fla., April 21, 2026 /PRNewswire/ -- Health In Tech, Inc. (Nasdaq: HIT) (the "Company"), an AI-enabled InsurTech platform company, today announced that it will be participating in the Market Movers Investor Summit on Tuesday, May 5, 2026.
Frequently Asked Questions
-
What is the current Health In Tech, Inc. (HIT) stock price?
-
Health In Tech, Inc.(NASDAQ:HIT) stock price is $1.13 in the last trading session. During the trading session, HIT stock reached the peak price of $4.02 while $0.85 was the lowest point it dropped to. The percentage change in HIT stock occurred in the recent session was 5.61% while the dollar amount for the price change in HIT stock was $0.06.
-
HIT's industry and sector of operation?
-
The NASDAQ listed HIT is part of Software - Application industry that operates in the broader Technology sector.
-
Who are the executives of HIT?
-
Sri Rajagopalan | Chief Technology Officer
Tim Johnson | Founder, Chief Executive Officer & Chairman
Zain Hasan | Chief Growth Officer
Julia Qian | Chief Financial Officer & Director
Michael Clarkson | Chief Information Security Officer -
How many employees does HIT have?
-
Number of HIT employees currently stands at 91. HIT operates from 701 S. Colorado Ave, Stuart, FL 34994, US.
-
Link for HIT official website?
-
Official Website of HIT is: https://healthintech.com
-
How do I contact HIT?
-
HIT could be contacted at phone #888 373 0333 and can also be accessed through its website. HIT operates from 701 S. Colorado Ave, Stuart, FL 34994, US.
-
How many shares of HIT are traded daily?
-
The average number of HIT shares traded daily for last 3 months was 188.99K.
-
What is the market cap of HIT currently?
-
The market value of HIT currently stands at $60.86M with its latest stock price at $1.13